The Independent Voice in Dental Prophylaxis
Editorial

State of Prophylaxis Q2 2026

Market, technology, and protocol trends in dental prophylaxis

Preventio Hub editorial team · Published April 21, 2026 · 11 pages · Free download · CC BY-NC 4.0

Download the report (PDF)

The full 11-page quarterly report, covering the European dental prophylaxis market, combined tabletop consolidation, erythritol consumables dynamics, protocol adoption, and H2 2026 outlook.

Download PDF (~28 KB)
DOI: to be registered on Zenodo · File: state-of-prophylaxis-q2-2026.pdf

What's in the report

The State of Prophylaxis Q2 2026 report synthesises Preventio Hub's editorial coverage from the first four months of 2026 and places it in the context of the wider European dental prophylaxis market. It is designed to give practitioners, procurement decision-makers, and industry analysts an independent quarterly read on where the category is moving.

Contents

  1. Executive summary
  2. European prophylaxis market overview
  3. Equipment: the combined tabletop consolidation — EMS AIRFLOW Prophylaxis Master, Mectron Combi Touch, NSK Varios Combi Pro2, Hu-Friedy PWR Air
  4. Consumables: erythritol's pricing pressure on EMS — six credible third-party SKUs now in European distribution
  5. Clinical protocols: GBT, iTOP, SRP
  6. Q1–Q2 2026 product launches and key news
  7. Clinical evidence updates
  8. Regulatory and standards context
  9. Outlook for H2 2026 and early 2027
  10. References and source articles

How to cite

Preventio Hub editorial team. (2026). State of Prophylaxis Q2 2026: Market, Technology, and Protocol Trends in Dental Prophylaxis. Preventio Hub.
Retrieved from https://preventiohub.com/editorial/state-of-prophylaxis-q2-2026/

A DOI will be registered via Zenodo and added to this page once processed. For academic and research use, please cite using the DOI once available. Until then, the URL citation above is canonical.

Licence

This report is published under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). You are free to share and adapt the material for non-commercial purposes with attribution. Attribution should reference "Preventio Hub editorial team" and link to the canonical URL. For commercial reuse, please contact the editorial team.

Editorial independence

Preventio Hub is an anonymous independent publication. The editorial team receives no sponsored content, no affiliate revenue, and no manufacturer funding. All specification, price, and clinical claims in the report are sourced from verifiable public documentation — see the "Never Invent" editorial policy at /editorial/.